Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma. Issue 6 (1st December 2018) - Schneider, Julia R; Shatzkes, Deborah R; Scharf, Stephen C; Tham, Tristan M; Kulason, Kay O; Buteau, François-Alexandre; Del Prete, Michela; Chakraborty, Shamik; Anderson, Todd A; Asiry, Saeed; Beauregard, Jean-Mathieu; Langer, David J; et al.